SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-054794
Filing Date
2006-03-15
Accepted
2006-03-15 13:53:21
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 753833
2 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1767
3 CERTIFICATION PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 10408
4 CERTIFICATION PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 10409
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5146
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 5159
  Complete submission text file 0001193125-06-054794.txt   788128
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 6175590033
PRO PHARMACEUTICALS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 06687625
SIC: 2834 Pharmaceutical Preparations